Taevas
Taevas provides end-to-end support for product registration across all life science sectors, ensuring your innovations reach patients and consumers worldwide with speed and compliance.
Product registration is the critical process of submitting comprehensive data and documentation to regulatory authorities to obtain approval for marketing and selling a product. This ensures safety, efficacy, and quality standards are met.
Taevas specializes in streamlining this complex process for life science products, leveraging deep regulatory expertise and a global network. We navigate diverse requirements, from initial submission to post-market vigilance, accelerating your path to market.
Achieve compliant, swift, and successful product launches across international borders.
Stay ahead with up-to-date insights on evolving global registration requirements.
Expert assembly of compliant submission packages, tailored to each market's specific format.
Develop optimal registration pathways to minimize delays and maximize market entry efficiency.
Coordinated submission and follow-up with regulatory bodies worldwide.
Our comprehensive approach to product registration is built on these foundational pillars, ensuring success at every stage of your global market entry.
In-depth research into target market regulations, identifying all requirements, guidelines, and potential challenges for your specific product type.
Crafting a tailored strategy that outlines the optimal pathway for registration, considering local nuances, timelines, and cost efficiencies.
Meticulous preparation and review of all necessary documentation, including technical files, clinical data, labeling, and quality systems, ensuring completeness and accuracy.
Direct communication and management of the submission process with national and international regulatory bodies, handling inquiries and facilitating approvals.
Ongoing support for post-market surveillance, adverse event reporting, variations, renewals, and maintaining continuous compliance.
Integrating registration efforts with broader market access strategies to ensure commercial viability and successful product launch.
A structured four-stage process that balances speed with rigour — typically complete in 4–6 weeks.
We align on objectives, geographies, therapy areas, and the specific business questions that need answering.
A 30–45 minute scoping call establishes the intelligence framework — ensuring every subsequent research hour is focused on decisions that matter.
Our deep understanding of diverse life science sectors enables us to provide targeted and effective product registration solutions.
From branded generics to biologics, we cover the full pharmaceutical value chain — clinical pipeline tracking, patent cliff analysis, and reimbursement modelling across regulated and emerging markets.
Our extensive global reach ensures your products can access markets around the world, regardless of complexity.
India · China · Japan · South Korea · Australia · Indonesia · Thailand · Vietnam · Philippines
Germany · France · UK · Italy · Spain · Netherlands · Switzerland · Poland · Sweden
United States · Canada · Brazil · Mexico · Colombia · Argentina · Chile
UAE · Saudi Arabia · Turkey · Israel · Egypt · Qatar
South Africa · Nigeria · Kenya · Ethiopia · Morocco
Bangladesh · Sri Lanka · Pakistan · Nepal · Myanmar
Every Taevas Product Registration engagement provides comprehensive outputs designed for clarity and actionable insights.
TAM/SAM/SOM with 5-year projections, segmented by product type, end user, and geography.
Profiling of top 10–15 players with pipeline, financials, positioning, and SWOT analysis.
Step-by-step approval guide, typical timelines, required dossiers, and local partner requirements.
Benchmark pricing across channels, reimbursement eligibility, and HTA decision landscape.
Prioritised strategy with recommended partnerships, channels, and launch sequencing.
Key opinion leaders, payer organisations, and the distributor ecosystem across target markets.
Interactive data visualisation summarising findings for C-suite and board presentations.
Post-delivery support to clarify findings, run scenario analyses, or refine recommendations.
Our Product Registration services are tailored to empower key stakeholders responsible for global product success and compliance.
Evaluating new market entry, product launches in new geographies, or acquisitions requiring deep commercial due diligence.
Conducting commercial due diligence, validating market size assumptions, or assessing competitive moats before committing capital.
Seeking investor-grade market data to underpin fundraising narratives, identify first-mover opportunities, or prioritise expansion.
Understanding sector landscapes, benchmarking policy environments, and identifying foreign investment opportunities in health and life sciences.
Translating academic research into commercial potential assessments, technology transfer opportunities, and licensing strategy.
White-label intelligence support for strategy and management consulting firms advising clients across life sciences markets.
Our analysts work exclusively in pharma, medtech, and consumer health. Every report reflects deep domain expertise — not generic research methodology applied to healthcare.
We don’t just aggregate public data. Every engagement includes primary interviews with regulators, KOLs, payers, and channel partners — intelligence you can’t Google.
Our network spans India, Southeast Asia, MENA, and Sub-Saharan Africa — markets that generic firms cover superficially but where the greatest growth opportunities exist.
We write for decision-makers, not archives. Every report includes a clear recommendation. Our readout sessions are structured for board discussions, not just information transfer.
Rapid-response turnarounds of 2–4 weeks for focused engagements — without sacrificing the rigour of primary research and expert validation.
Our 30-day Q&A window, ongoing subscriptions, and retainer models mean we’re a long-term intelligence partner — not a one-off vendor.
“Taevas transformed our approach to product registration. Their expertise and seamless global coordination saved us months, ensuring our critical new therapy reached patients faster than anticipated.”
Product Registration is often the starting point. Complement your market entry with these related Taevas services.
From regulatory pathway mapping to full dossier preparation and submission management across global markets.
Shortlisting, evaluating, and connecting you with validated in-market partners, distributors, and licensing candidates.
Optimise launch pricing, reimbursement positioning, and access pathways to maximise commercial success from day one.
Scientific communication strategy, publication planning, and structured KOL engagement programmes for new market entrants.
Investor-grade commercial assessments for M&A, licensing deals, or fundraising — with rapid turnaround for live transactions.
Monthly or quarterly market monitoring — competitive signals, regulatory updates, and commercial developments as a managed service.
Partner with Taevas to navigate the complexities of global product registration and accelerate your market entry with confidence.